Omega Healthcare Investors Inc (NYSE:OHI) – Analysts at SunTrust Banks lowered their Q1 2018 earnings estimates for Omega Healthcare Investors in a research report issued to clients and investors on Wednesday, according to Zacks Investment Research. SunTrust Banks analyst E. Fleming now expects that the real estate investment trust will earn $0.72 per share for the quarter, down from their previous forecast of $0.79. SunTrust Banks has a “Hold” rating and a $26.00 price objective on the stock. SunTrust Banks also issued estimates for Omega Healthcare Investors’ Q2 2018 earnings at $0.71 EPS, Q3 2018 earnings at $0.73 EPS, Q4 2018 earnings at $0.75 EPS, Q1 2019 earnings at $0.77 EPS, Q2 2019 earnings at $0.78 EPS, Q3 2019 earnings at $0.78 EPS and Q4 2019 earnings at $0.79 EPS.
Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Tuesday, February 13th. The real estate investment trust reported $0.31 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.49 by ($0.18). Omega Healthcare Investors had a net margin of 11.06% and a return on equity of 2.48%. The firm had revenue of $221.21 million for the quarter, compared to analysts’ expectations of $219.07 million.
OHI has been the topic of several other research reports. ValuEngine upgraded shares of Omega Healthcare Investors from a “hold” rating to a “buy” rating in a research note on Friday, December 15th. Zacks Investment Research cut shares of Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research note on Tuesday, January 2nd. Cantor Fitzgerald restated a “buy” rating and set a $34.00 target price on shares of Omega Healthcare Investors in a research note on Wednesday, March 7th. Jefferies Group restated an “underperform” rating on shares of Omega Healthcare Investors in a research note on Thursday, December 21st. Finally, Stifel Nicolaus reaffirmed a “hold” rating and set a $27.00 price objective (down from $29.00) on shares of Omega Healthcare Investors in a report on Wednesday, February 14th. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $31.37.
Shares of Omega Healthcare Investors (NYSE:OHI) traded up $0.02 during mid-day trading on Monday, reaching $27.32. 1,409,783 shares of the company traded hands, compared to its average volume of 2,850,000. The company has a quick ratio of 3.55, a current ratio of 3.55 and a debt-to-equity ratio of 1.18. The stock has a market cap of $5,430.00, a P/E ratio of 59.39, a price-to-earnings-growth ratio of 3.12 and a beta of 0.46. Omega Healthcare Investors has a one year low of $24.90 and a one year high of $35.14.
Hedge funds have recently bought and sold shares of the stock. Barnett & Company Inc. grew its holdings in shares of Omega Healthcare Investors by 1,980.0% in the third quarter. Barnett & Company Inc. now owns 5,200 shares of the real estate investment trust’s stock valued at $166,000 after purchasing an additional 4,950 shares in the last quarter. Mcmillion Capital Management Inc. purchased a new position in shares of Omega Healthcare Investors in the third quarter valued at $201,000. Lourd Capital LLC purchased a new position in shares of Omega Healthcare Investors in the fourth quarter valued at $202,000. Timber Hill LLC purchased a new position in shares of Omega Healthcare Investors in the third quarter valued at $206,000. Finally, Good Life Advisors LLC purchased a new position in shares of Omega Healthcare Investors in the third quarter valued at $209,000. 73.86% of the stock is owned by hedge funds and other institutional investors.
In other Omega Healthcare Investors news, Director Bernard J. Korman bought 100,000 shares of the business’s stock in a transaction that occurred on Friday, December 22nd. The stock was purchased at an average cost of $26.89 per share, with a total value of $2,689,000.00. Following the completion of the acquisition, the director now owns 896,895 shares in the company, valued at approximately $24,117,506.55. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.54% of the company’s stock.
The firm also recently announced a quarterly dividend, which was paid on Thursday, February 15th. Investors of record on Wednesday, January 31st were issued a $0.66 dividend. The ex-dividend date of this dividend was Tuesday, January 30th. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.65. This represents a $2.64 dividend on an annualized basis and a dividend yield of 9.66%. Omega Healthcare Investors’s dividend payout ratio (DPR) is 573.91%.
ILLEGAL ACTIVITY NOTICE: This piece was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright legislation. The correct version of this piece can be viewed at https://ledgergazette.com/2018/03/15/q1-2018-eps-estimates-for-omega-healthcare-investors-inc-ohi-cut-by-analyst.html.
Omega Healthcare Investors Company Profile
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.